Impact of Preoperative Counseling and Education in Reducing Anxiety Levels in Patients With Gynecologic Tumors
NCT ID: NCT03574155
Last Updated: 2019-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
274 participants
INTERVENTIONAL
2018-08-15
2019-08-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Centering Pre-operative Counseling on Patient Reported Anxiety
NCT04068675
Emotional Impact of the Way Conducting Cancer Patients to the Surgical Center
NCT03576482
Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants
NCT00127465
The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies
NCT00726635
Surveillance Pelvic Examination Anxiety: Brief Coping Skills Intervention
NCT05285306
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
Experimental Group Pre-operative Counseling and Education Application of the questionnaire (ESAS) and (HADS)
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control- group
It is composed of patients scheduled for surgical treatment by tumors of the uterine cervix, vulva, ovary or endometrium, who will receive preoperative and postoperative guidelines according to the usual routine for the perioperative period of the present institution. Patients and their followers of the control group will participate in a preoperative consultation with the surgeon to discuss the indication of the procedure and its risks, benefits and alternatives to the procedure being indicated, if any.
Pre-operative Counseling and Education Application of the questionnaire (ESAS) and (HADS)
No interventions assigned to this group
Experimental Group
Composed of patients scheduled for surgical treatment by tumors of the uterine cervix, vulva, ovary or endometrium who will receive preoperative counseling and education through a pre-defined protocol after preoperative consultation with the surgeon. The counseling session will take place with at least one companion. The purpose of this session is to supplement, re-emphasize and strengthen the perioperative guidelines. An illustration (explanatory folder) will be used to demonstrate the location of the surgery, how the scar will be and on which sites of the abdomen and organs the surgery will cover. All this counseling and education will be applied at the same time to the patient and her companion. At the end of the intervention, a space will be left open for both the patient and the companion to ask questions and questions.
Pre-operative Counseling and Education Application of the questionnaire (ESAS) and (HADS)
Pre-operative Counseling and Education
Group control Pre-operative Orientation Routine Application of the questionnaire (ESAS) and (HADS) Post-operative Immediate (1 OP) Application of the Questionnaire to assess HADS and ESAS Anxiety (Patient)
Experimental Group Pre-operative Counseling and Education Application of the questionnaire (ESAS) and (HADS)
Late postoperative (2 - 4 weeks) Questioning the patient and companion evaluating the degree of satisfaction regarding the preoperative guidelines.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pre-operative Counseling and Education
Group control Pre-operative Orientation Routine Application of the questionnaire (ESAS) and (HADS) Post-operative Immediate (1 OP) Application of the Questionnaire to assess HADS and ESAS Anxiety (Patient)
Experimental Group Pre-operative Counseling and Education Application of the questionnaire (ESAS) and (HADS)
Late postoperative (2 - 4 weeks) Questioning the patient and companion evaluating the degree of satisfaction regarding the preoperative guidelines.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary therapy, which may be radiotherapy or chemotherapy.
* Patients between the ages of 20 and 80 years.
* Patients submitted to a laparotomic or minimally invasive method (robotic and laparoscopic).
* Patients should be treated at the Oncology Gynecology Service of the Barretos Cancer Hospital.
Exclusion Criteria
* Patients who have already been treated for some other cancer in the past.
* Patients without a complete primary level and / or who can not read or write.
* Patients and / or family members who refuse to participate in the study.
* Patients who will be admitted to the ICU.
20 Years
80 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Barretos Cancer Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ricardo dos Reis
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ricardo Reis
Barretos, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
81886517000005437
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.